- BioNTech schedules virtual annual general meeting in Mainz on May 15, 2026.
- Shareholders vote on proposal to carry forward 2025 balance sheet profit of EUR 6.9 billion.
- Resolutions include discharge votes for management board, supervisory board.
- Meeting also seeks approval to expand supervisory board to eight members, including elections and re-elections of five nominees.
- Other items include reauthorizing virtual AGM format, creating new authorized capital of EUR 129.5 million through May 15, 2030, approval of domination and profit transfer agreement with BioNTech Discovery.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001776985-26-000025), on April 02, 2026, and is solely responsible for the information contained therein.
Comments